Key result
Arsenic trioxide therapy caused monomorphic ventricular tachycardia without QT interval prolongation in a patient with acute promyelocytic leukaemia.
Answers are grounded in this paper and cite their sources.
Arsenic trioxide therapy can cause ventricular arrhythmias even in the absence of QT prolongation.
Arsenic trioxide has become the treatment of choice for patients with acute promyelocytic leukaemia. Cardiovascular toxicity is known to occur with this therapy, in particular heart rhythm disorders due to QT interval prolongation. We present a case of ventricular arrhythmia with no QT prolongation in a patient receiving arsenic trioxide therapy.
No takes yet. Share an insight, caveat, or question.
Ducas et al. (2011) studied this question. Arsenic trioxide therapy caused monomorphic ventricular tachycardia without QT interval prolongation in a patient with acute promyelocytic leukaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: